NYSE:ELV

Elevance Health Q2 2026 Earnings Report

Elevance Health logo
$388.77 +0.27 (+0.07%)
Closing price 06/18/2026 03:59 PM Eastern
Extended Trading
$384.89 -3.88 (-1.00%)
As of 06/18/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elevance Health EPS Results

Actual EPS
N/A
Consensus EPS
$6.17
Beat/Miss
N/A
One Year Ago EPS
N/A

Elevance Health Revenue Results

Actual Revenue
N/A
Expected Revenue
$48.80 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elevance Health Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Thursday, July 16, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Elevance Health Earnings Headlines

Elevance Health Reaffirms 2026 Earnings and Cost Targets
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of the profits are typically already gone. SpaceX insiders bought in at a $20 billion valuation - you're being offered entry at $1.75 trillion. But one small, publicly traded company sits directly in SpaceX's supply chain, still priced like Wall Street hasn't noticed. It powers critical infrastructure Musk's operation can't run without. Dylan Jovine is naming it today, free.tc pixel
See More Elevance Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elevance Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevance Health and other key companies, straight to your email.

About Elevance Health

Elevance Health (NYSE:ELV) (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc. to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products. The company also delivers administrative services and clinical care-management solutions, operates pharmacy benefit services, and provides digital tools meant to support care coordination, population health management and member engagement. Through its operating units, Elevance contracts with provider networks and develops programs aimed at improving quality of care and managing costs.

Elevance primarily serves customers across the United States, working with employers, state and federal health programs, providers and other stakeholders in the U.S. health-care system. In addition to its insurance businesses, the company has built out a suite of health services and care-delivery capabilities intended to support value-based care initiatives and expand non-insurance offerings. Its scale and national footprint position Elevance to participate in a variety of care models and payment arrangements as the U.S. health-care landscape evolves.

View Elevance Health Profile